Cited 36 times in
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.